search
Back to results

Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study (CUPIP)

Primary Purpose

Iron-deficiency, Iron Deficiency Anemia, Micronutrient Deficiency

Status
Completed
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
Vitamin and Mineral Powder
Sponsored by
University of Malaya
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Iron-deficiency

Eligibility Criteria

6 Months - 5 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children aged 6 months to 5 years living in PPR Lembah Subang

Exclusion Criteria:

  • Ex-premature babies and children with congenital abnormalities resulting in gross impairment
  • Children whose caregiver did not consent to participation

Sites / Locations

  • University of Malaya Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Supplementation Group

Control Group

Arm Description

Receives baseline deworming medication. Intervention: receive daily micronutrient supplementation packets- 4 month supply, to be taken every day. Blood iron and anthropometric measurements taken at 0 and 4 months.

Receives baseline deworming medication. Blood iron and anthropometric measurements taken at 0 and 4 months.

Outcomes

Primary Outcome Measures

Change in serum ferritin level between baseline and after 4 months mineral supplementation
Blood test for serum ferritin level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).
Change in reticulocyte hemoglobin level between baseline and after 4 months mineral supplementation
Blood test for RET-He level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).
Change in C-reactive protein level between baseline and after 4 months mineral supplementation
Blood test for C-reactive protein level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).

Secondary Outcome Measures

Change in height (cm)
Height of child will be measured at baseline (0 months) and after 4 months mineral supplementation (or no supplementation for control group).
Change in weight (kg)
Weight of child will be measured at baseline (0 months) and after 4 months mineral supplementation (or no supplementation for control group).

Full Information

First Posted
January 15, 2019
Last Updated
August 28, 2022
Sponsor
University of Malaya
search

1. Study Identification

Unique Protocol Identification Number
NCT03819530
Brief Title
Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study
Acronym
CUPIP
Official Title
A Pilot Study of Micronutrient Supplementation for Child of Urban Poverty Iron Project in Selangor, Malaysia
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
September 16, 2019 (Actual)
Primary Completion Date
February 29, 2020 (Actual)
Study Completion Date
March 15, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Malaya

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The first 1,000 days of life are critical periods for brain development. Proper nutrition lays the foundation for optimal growth, health, and neurodevelopment across the lifespan. Poor nutrition in this vulnerable period has irreversible consequences, including stunting, susceptibility to sickness, reduced school performance and productivity, and impaired intellectual and social development. UNICEF reported in 2018 that among the low cost flat residents in urban areas of the Klang Valley, 15% of children under 5 years old were stunted, 22% underweight, and 23% either overweight or obese. Will a micronutrient supplementation program improve the growth and iron status of children aged 6 months to 5 years staying in Lembah Subang? Children will be randomized into treatment and control groups. Treatment groups will receive dietary micronutrient supplementation packets. Measurements of height and weight and iron status will be taken at baseline and 4 months later.
Detailed Description
This is a pilot study in a single-centre, using a single-blind, two-parallel group, randomized trial conducted amongst children aged 6 months to 5 years residing at PPR Lembah Subang, located in the state of Selangor, Malaysia between October 2019 and February 2020 (4 months). The participants were randomly assigned in a 3:2 treatment-to-control allocation to receive, in addition to the baseline deworming treatment, either daily micronutrient packets for 4 months (intervention arm) or no micronutrient supplementation (control group). This residency area comprises a local population with mixed ethnic makeup and poor socioeconomic status (majority are B40). We distributed flyers, posters, and leaflets with the help of the community mothers in PPR communities to encourage participation. Registration, informed consent and anthropometric measurements, dietary logs and blood drawn for iron status were taken prior to randomization. All children received a baseline deworming treatment at this point. The treatment group received baseline deworming medications, a 4-month supply of daily micronutrient supplementation and a compliance monitoring log. The control group only received similar baseline deworming medications without any daily micronutrient supplementation. Only the research investigators and outcome assessors were masked to the treatment status whilst the participants and interventionists research investigators were aware of the assigned intervention. Primary endpoints assessed in this study are changes in serum ferritin and hemoglobin levels at 0 and 4 months after interventions. The secondary endpoints are changes in age-and-sex standardized height and weight percentile scores at 0 and 4 months after micronutrient supplementation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Iron-deficiency, Iron Deficiency Anemia, Micronutrient Deficiency, Nutrient Deficiency, Stunting

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Treatment group: receives baseline deworming medication and daily micronutrient supplementation for 4 months; Control group: receives baseline deworming medication only
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
45 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Supplementation Group
Arm Type
Experimental
Arm Description
Receives baseline deworming medication. Intervention: receive daily micronutrient supplementation packets- 4 month supply, to be taken every day. Blood iron and anthropometric measurements taken at 0 and 4 months.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Receives baseline deworming medication. Blood iron and anthropometric measurements taken at 0 and 4 months.
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin and Mineral Powder
Other Intervention Name(s)
Multiple Micronutrient Powder
Intervention Description
Vitamin and mineral nutritional supplement. Each packet is 1g of powder, to be taken with food.
Primary Outcome Measure Information:
Title
Change in serum ferritin level between baseline and after 4 months mineral supplementation
Description
Blood test for serum ferritin level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).
Time Frame
First blood test upon enrollment, at 0 months. Second blood test at 4 months
Title
Change in reticulocyte hemoglobin level between baseline and after 4 months mineral supplementation
Description
Blood test for RET-He level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).
Time Frame
First blood test upon enrollment, at 0 months. Second blood test at 4 months
Title
Change in C-reactive protein level between baseline and after 4 months mineral supplementation
Description
Blood test for C-reactive protein level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).
Time Frame
First blood test upon enrollment, at 0 months. Second blood test at 4 months
Secondary Outcome Measure Information:
Title
Change in height (cm)
Description
Height of child will be measured at baseline (0 months) and after 4 months mineral supplementation (or no supplementation for control group).
Time Frame
First height measurement upon enrollment at 0 months. Second height measurement at 6 months.
Title
Change in weight (kg)
Description
Weight of child will be measured at baseline (0 months) and after 4 months mineral supplementation (or no supplementation for control group).
Time Frame
First weight measurement upon enrollment at 0 months. Second weight measurement at 4 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children aged 6 months to 5 years living in PPR Lembah Subang Exclusion Criteria: Ex-premature babies and children with congenital abnormalities resulting in gross impairment Children whose caregiver did not consent to participation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lucy Chai See Lum, MD
Organizational Affiliation
University Malaya, Faculty of Medic
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Malaya Medical Center
City
Kuala Lumpur
State/Province
Wilayah Persekutuan Kuala Lumpur
ZIP/Postal Code
59100
Country
Malaysia

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Not planning to share patient data.

Learn more about this trial

Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study

We'll reach out to this number within 24 hrs